Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
46,764,551
-
Share change
-
-4,543,582
-
Total reported value
-
$7,652,437,559
-
Put/Call ratio
-
95%
-
Price per share
-
$163.65
-
Number of holders
-
853
-
Value change
-
-$736,351,962
-
Number of buys
-
358
-
Number of sells
-
322
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2021
As of 30 Jun 2021,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
853 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,764,551 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, GOLDMAN SACHS GROUP INC, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, JPMORGAN CHASE & CO, BARCLAYS PLC, and ROYAL BANK OF CANADA.
This page lists
853
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.